Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
C. B. Karsten, F. F. R. Buttner, S. Cajic, I. Nehlmeier, B. Roshani, A. Klippert, U. Sauermann, N. Stolte-Leeb, U. Reichl, R. Gerardy-Schahn, E. Rapp, C. Stahl-Hennig, S. Pohlmann
This study compares glycosylation, infectivity, and neutralization sensitivity of SIV produced in macrophages versus CD4+ T cells, revealing differences in glycan profiles and their impact on viral spread and antibody neutralization.
bioRxiv · Jan 2, 2024Microbiology